Position in ALKS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,065,187
-$14,177 QoQ
Shares Held
20,328
-33.4% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#209
of 421 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DNB Asset Management AS holds $45,753,224 across 11 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
120,337 | $20,281,597 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
245,245 | $8,308,900 | |
| 3 | ZTS |
Zoetis Inc.
|
101,556 | $7,297,814 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
8,646 | $4,684,662 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
55,147 | $1,911,946 | |
| 6 | ALKS |
Alkermes plc.
This page
|
20,328 | $1,065,187 | |
| 7 | VTRS |
Viatris Inc
|
48,883 | $776,262 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
24,879 | $612,272 |
All Filings in ALKS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,065,187 | 20,328 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $1,079,364 | 30,525 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $860,720 | 30,762 | Shares | Other | 2026-02-05 | |
| 2025-09-30 | $396,900 | 13,230 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $327,470 | 11,446 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $327,822 | 9,928 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $378,941 | 13,176 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $415,063 | 14,829 | Shares | Other | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||